Medicare Enrolled

Dr. Patrick Hogan, D.O.

Neurology · Tacoma, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
5006 CENTER ST STE U, Tacoma, WA 98409
2532844488
In practice since 2005 (21 years)
NPI: 1245237734 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hogan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hogan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hogan

Dr. Patrick Hogan is a neurology specialist in Tacoma, WA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Hogan performed 144,693 Medicare services across 586 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hogan received a total of $143,075 from 46 pharmaceutical and/or device companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hogan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 0% volume in WA $143,075 industry payments

Medicare Practice Summary

Medicare Utilization ↗
144,693
Medicare services
Top 0% in WA for neurology
586
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,890 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
103,824 $5 $6
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
23,900 $4 $6
AbobotulinumtoxinA injection, 5 units
An injection of abobotulinumtoxinA administered in a quantity of 5 units.
15,700 $6 $8
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
401 $129 $320
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 390 $61 $150
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
232 $90 $320
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
72 $42 $115
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
67 $72 $155
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
37 $113 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $65 $135
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity 34 $67 $119
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$143,075
Total received (2018-2024)
Avg $20,439/year across 7 years
Top 3% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
714
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$127,862 (89.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,734 (6.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,479 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,527
2023
$2,792
2022
$14,033
2021
$25,301
2020
$21,575
2019
$49,743
2018
$28,104

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$497
Teva Pharmaceuticals USA, Inc.
$240
Ipsen Biopharmaceuticals, Inc
$161
Merz Pharmaceuticals, LLC
$145
PFIZER INC.
$98
REVANCE THERAPEUTICS, INC.
$96
Acorda Therapeutics, Inc
$81
Amneal Pharmaceuticals LLC
$58
Lilly USA, LLC
$56
Cala Health, Inc.
$38
Neuronetics, Inc.
$31
Lundbeck LLC
$26
Top 3 companies account for 58.9% of 2024 payments
All-time payments by company (2018-2024) ›
Avanir Pharmaceuticals, Inc.
$34,416
Allergan, Inc.
$25,609
Allergan Inc.
$20,132
Teva Pharmaceuticals USA, Inc.
$15,746
Ipsen Biopharmaceuticals, Inc
$12,370
Neurocrine Biosciences, Inc.
$11,125
AbbVie Inc.
$10,210
ABBVIE INC.
$9,032
Merz Pharmaceuticals, LLC
$563
ACADIA Pharmaceuticals Inc
$547
Lilly USA, LLC
$254
Amgen Inc.
$249
Upsher-Smith Laboratories LLC
$245
PFIZER INC.
$238
UPSHER-SMITH LABORATORIES LLC
$200
Amneal Pharmaceuticals LLC
$193
Acorda Therapeutics, Inc
$192
Lundbeck LLC
$154
Merz North America, Inc.
$150
Promius Pharma LLC
$141
Bausch Health US, LLC
$121
MDD US Operations, LLC
$103
Supernus Pharmaceuticals, Inc.
$99
REVANCE THERAPEUTICS, INC.
$96
Boston Scientific Corporation
$93
Vertical Pharmaceuticals, LLC
$91
Zyla Life Sciences, Inc.
$68
Kyowa Kirin, Inc.
$67
Neuronetics, Inc.
$66
ASSERTIO THERAPEUTICS, Inc.
$54
US WorldMeds, LLC
$51
Biohaven Pharmaceutical Holding Company Ltd.
$43
Biohaven Pharmaceuticals, Inc.
$40
Cala Health, Inc.
$38
IMPEL PHARMACEUTICALS INC.
$38
MERZ NORTH AMERICA, INC.
$33
ARBOR PHARMACEUTICALS, INC.
$32
Assertio Therapeutics, Inc.
$27
AbbVie, Inc.
$26
Ironwood Pharmaceuticals, Inc
$24
Alexion Pharmaceuticals, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$18
Arbor Pharmaceuticals, Inc.
$18
Currax Pharmaceuticals LLC
$16
Novartis Pharmaceuticals Corporation
$14
Almatica Pharma LLC
$12
Top 3 companies account for 56.0% of all-time payments
Associated products mentioned in payments ›
AJOVY · APLENZIN · APOKYN · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · CALA KIQ · CONTRAVE · COPAXONE · Cambia · DAXXIFY · DIVIGEL · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · Edarbi · GOCOVRI · GRALISE · General - DBS · Gralise · Horizant · INBRIJA · INGREZZA · Linzess · MIGRANAL · MYOBLOC · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · ONGENTYS · ONZETRA Xsail · OSMOLEX ER · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RYTARY · SOLIRIS · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VYALEV · VYEPTI · Vercise · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in WA.

Looking for a neurology specialist in Tacoma?
Compare neurologists in the Tacoma area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
68
Per 100K population
7.4
County median income
$96,632
Nearest hospital
ST JOSEPH MEDICAL CENTER
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hogan is a mixed practice specialist, with above-average Medicare volume (top 0% in WA), with speaking/promotional industry engagement in the top 3% of WA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hogan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Hogan performed 103,824 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hogan receive payments from pharmaceutical companies?
Yes. Dr. Hogan received a total of $143,075 from 46 companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hogan's costs compare to other neurologists in Tacoma?
Dr. Hogan's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hogan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →